Omicron virus. (IANS infographics)
Reinfection reports for Omicron have been making rounds for a long time and the window of protection from past infection may have been reduced from 12 weeks to 28 days.
Written by Arushi Bidhuri | Updated: July 18, 2022 6:16 PM
Many people have been vaccinated against coronavirus with the most emerging variants in the world. With freely moving variants, COVID cases may increase again. As subvariants increase in the world, many people who have been vaccinated against COVID are afraid of reinfection. It turns out that new subvariants may be susceptible to reinfection sooner rather than later.
Omicron reinfection may be rather
Health experts said the protection window from the last infection has been shortened from 12 weeks to 28 days. The governments of New South Wales, Western Australia and the Australian Capital Territory have announced this week that those who have previously taken Covid-19 should retest 28 days later if they show symptoms. They will be treated as new cases if the test is positive.
Reinfection is on the rise and refers to testing positive for SARS-CoV-2, the virus that causes Covid, after recovering from a previous infection. In the pre-Omicron period, reinfection accounted for 1 per cent of all cases in England, but in recent weeks, accounted for more than 25 per cent of daily cases there and 18 per cent in the city of New York. York.
Although we lack comparable data for Australia, given the introduction of Omicron BA.4 and BA.5 subvariants, the situation is likely to be similar. These can spread more easily and, in people who have already been vaccinated or infected, lead to advanced infections.
The virus itself, such as a person’s immune response to previous COVID infection, their vaccination status, and personal safety measures are the four main aspects that help us understand our risk of reinfection at the individual level. . While the first two things are out of our control, you can work on the other two to see the difference.
Vaccinated people are prone to reinfection
Although vaccination is the best defense against coronavirus, some variants may escape antibodies produced after vaccination. Omicron strains have developed ways to prevent antibody neutralization of the vaccine, so they can still infect people who have received the vaccinations.
A study published in The New England Journal of Medicine found that antibody levels against all Omicron subvariants are reduced after the second dose of an mRNA vaccination. In other words, vaccination loses its effectiveness more quickly against virus subvariants than against the original strain. Two weeks after participants received a booster vaccine, antibody levels in all variants increased once again, however, BA.4 and BA.5 demonstrated the smallest incremental gains.
Total well-being is now just a click away.
Follow us on